|
Market Closed -
Euronext Paris
11:55:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.3360 EUR | +1.66% |
|
-2.33% | +12.75% |
| 09-11 | Chinese Regulator Accepts Nicox's Glaucoma Drug Application for Review | MT |
| 09-11 | Nicox S.A. Announces Acceptance Of NCX 470 NDA For Review In China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NICOX SA | Specialty & Advanced Pharmaceuticals | +1.66% | -2.33% | +12.75% | -8.20% | -90.65% | 33.44M |  | |  |
- Stock Market
- Stocks
- ALCOX Stock
- Charts Nicox SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
